American Association of Clinical Endocrinologists Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome.
D002318:Cardiovascular Diseases / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology; D004704:Endocrinology; D004730:Endothelium, Vascular / Q000503:physiopathology; D005260:Female; D006801:Humans; D007333:Insulin Resistance; D008659:Metabolic Diseases / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology; D011085:Polycystic Ovary Syndrome / Q000150:complications* / Q000378:metabolism / Q000503:physiopathology; D012955:Societies, Medical; D014481:United States